Overview of the potential blockbusters pipeline of 2018CHEN Ling, ZHOU Xin-yuan, ZHANG Jing, HUANG Wen-long1449-1459
The role of national quality evaluation in enhancing the quality of chemical antiviral drugsZHU Jiong, LIU Yang, HE Lan1460-1464
Analysis of patent application situation of elemeneZHENG Jing-sheng, JIN Li-si, WANG Sun-fu, GE Wei-hong1471-1475
Application of next generation sequencing technology in genotoxicity researchYU Chun-rong, YUAN Tai-chang, ZHOU Chang-hui, HUANG Peng-cheng, TONG Wen, LI Ruo-wan, WANG Qing-li, CHANG Yan1476-1482
The application of joint model on the multiple endpoints for the therapeutic effect evaluation of traditional Chinese medicineLU Fang, LI Song-lin, LI Yang, YI Dan-hui, TANG Xu-dong1483-1490
Research progress on the evaluation of new drugs' immunotoxicityPAN Dong-sheng, FAN Yu-ming, LI Bo1491-1495
N-glycan analysis of soluble CD95-Fc by UPLC/MSYU Lei, TAO Lei, LI Xiang, GUO Ying, RAO Chun-ming1496-1501
Advances in the research of TOPK and its inhibitors in oncologySUN Yu-tong, SONG Shu-yong, YANG Yi-qiu, WANG Gui-fei, XIE Xiao-yang, HUANG Yun-sheng1502-1509
Advances in research of anti-tumor targeting performance of liposomesPENG Ying, TANG Ying-nan, ZHOU Li-li, YANG Jing, QIAO Yong, ZOU Man-shu, XIA Xin-hua1510-1514